Jeziorska, D. M.
Tunnacliffe, E. A. J. http://orcid.org/0000-0003-3939-744X
Brown, J. M. http://orcid.org/0000-0002-8884-2047
Ayyub, H.
Sloane-Stanley, J.
Sharpe, J. A.
Lagerholm, B. C. http://orcid.org/0000-0003-4678-5168
Babbs, C. http://orcid.org/0000-0002-1898-5878
Smith, A. J. H.
Buckle, V. J. http://orcid.org/0000-0003-1195-2608
Higgs, D. R. http://orcid.org/0000-0003-3579-8705
Funding for this research was provided by:
RCUK | Medical Research Council (MR/T014067/1, MC_UU_00016/4)
Article History
Received: 8 December 2021
Accepted: 7 October 2022
First Online: 4 November 2022
Competing interests
: D.M.J. is co-founder of Nucleome Therapeutics. The remaining authors declare no competing interests.